These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV; Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174 [TBL] [Abstract][Full Text] [Related]
3. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349 [TBL] [Abstract][Full Text] [Related]
4. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study. Tancin Lambert A; Ratajczak-Tretel B; Al-Ani R; Arntzen K; Bakkejord GK; Bekkeseth HMO; Bjerkeli V; Eldøen G; Gulsvik AK; Halvorsen B; Høie GA; Ihle-Hansen H; Ihle-Hansen H; Ingebrigtsen S; Johansen H; Kremer C; Krogseth SB; Kruuse C; Kurz M; Nakstad I; Novotny V; Naess H; Qazi R; Rezai MK; Rørholt DM; Steffensen LH; Sømark J; Tobro H; Truelsen TC; Wassvik L; AEgidius KL; Pesonen M; de Melis M; Atar D; Aamodt AH; Eur J Neurol; 2023 May; 30(5):1352-1363. PubMed ID: 36786305 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation. Kuronuma K; Okumura Y; Morikawa T; Yokoyama K; Matsumoto N; Tachibana E; Oiwa K; Matsumoto M; Kojima T; Haruta H; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A; Int Heart J; 2020 May; 61(3):492-502. PubMed ID: 32418966 [TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke. Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545 [TBL] [Abstract][Full Text] [Related]
9. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance. Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921 [TBL] [Abstract][Full Text] [Related]
12. Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies. Cameron AC; Arnold M; Katsas G; Yang J; Quinn TJ; Abdul-Rahim AH; Campbell R; Docherty K; De Marchis GM; Arnold M; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Foerch C; Spanaus K; Eckardstein AV; Dawson J; Katan M Neurology; 2024 Aug; 103(3):e209625. PubMed ID: 38950311 [TBL] [Abstract][Full Text] [Related]
13. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure. Schnorbach J; Fröhlich H; Täger T; Corletto A; Katus HA; Frankenstein L ESC Heart Fail; 2019 Aug; 6(4):640-648. PubMed ID: 31259484 [TBL] [Abstract][Full Text] [Related]
14. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients. Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935 [TBL] [Abstract][Full Text] [Related]
15. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation. Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808 [TBL] [Abstract][Full Text] [Related]